Koyas Perfumery And Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 19 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.47 Cr
as on 23-10-2024
- Revenue -7.01%
(FY 2023)
- Profit -37.10%
(FY 2023)
- Ebitda 10.95%
(FY 2023)
- Net Worth 59.92%
(FY 2023)
- Total Assets 11.81%
(FY 2023)
About Koyas Perfumery And Pharma
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.47 Cr.
Nanguveetil Aboobackar and Ahmed Nanguveetil serve as directors at the Company.
- CIN/LLPIN
U24241KA2005PTC037927
- Company No.
037927
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore., Karnataka
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Koyas Perfumery And Pharma Private Limited offer?
Koyas Perfumery And Pharma Private Limited offers a wide range of products and services, including Bath Soaps, Rose Soap, Organic Soap, Cucumber Soap.
Who are the key members and board of directors at Koyas Perfumery And Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ahmed Nanguveetil  | Managing Director | 12-Dec-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nanguveetil Aboobackar | Director | 12-Dec-2005 | Current |
Financial Performance of Koyas Perfumery And Pharma.
Koyas Perfumery And Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.01% decrease. The company also saw a substantial fall in profitability, with a 37.1% decrease in profit. The company's net worth Soared by an impressive increase of 59.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koyas Perfumery And Pharma?
In 2023, Koyas Perfumery And Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Jun 2022 | ₹2.40 Cr | Open |
Others Creation Date: 15 Oct 2018 | ₹0.67 M | Open |
How Many Employees Work at Koyas Perfumery And Pharma?
Koyas Perfumery And Pharma has a workforce of 23 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koyas Perfumery And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koyas Perfumery And Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
